OAM
AMED

Oberweis Asset Management’s Amedisys AMED Stock Holding History

Oberweis Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,402
Closed -$636K – 161
2021
Q1 		$636K Sell
2,402
-450
-16% -$127K 0.13% 107
2020
Q4 		$837K Sell
2,852
-148
-5% -$37.9K 0.22% 69
2020
Q3 		$709K Sell
3,000
-200
-6% -$45.5K 0.24% 70
2020
Q2 		$635K Sell
3,200
-3,095
-49% -$577K 0.25% 73
2020
Q1 		$1.16M Sell
6,295
-760
-11% -$135K 0.64% 28
2019
Q4 		$1.18M Buy
+7,055
New +$1.05M 0.39% 55
2018
Q4 		– Sell
-2,200
Closed -$275K – 197
2018
Q3 		$275K Buy
+2,200
New +$243K 0.05% 193

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Oberweis Asset Management's AMED Position: Q2 2021 in Review

Oberweis Asset Management sold out of Amedisys (AMED) in Q2 2021, closing a stake of 2,402 shares — an estimated $636K sold.

Oberweis Asset Management first reported a position in AMED in Q3 2018 and held it in 7 quarters. The position peaked at $1.18M in Q4 2019. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Oberweis Asset Management reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Oberweis Asset Management sold 2,402 Amedisys shares in Q2 2021, an estimated $636K.
  • Oberweis Asset Management first reported a position in Amedisys in Q3 2018 and held it in 7 quarters.
  • Oberweis Asset Management's Amedisys position peaked at $1.18M in Q4 2019.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Oberweis Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.